HEAD AND NECK CANCER (H&N)
Clinical trials for HEAD AND NECK CANCER (H&N) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER (H&N) trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER (H&N), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation therapy tested for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a two-part approach for people with advanced cancers that cannot be removed by surgery. First, a special imaging scan is used to see if a tumor has a specific target. If it does, a targeted radiation treatment is given to try to control the cancer. The main …
Matched conditions: HEAD AND NECK CANCER (H&N)
Phase: PHASE1, PHASE2 • Sponsor: ITM Oncologics GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
AI test aims to match cancer patients with right drugs
Diagnosis Recruiting nowThis study is testing a new diagnostic platform that uses artificial intelligence to analyze small pieces of a patient's tumor. The goal is to predict whether a patient's cancer will respond to immunotherapy drugs before they start treatment. Researchers will compare the AI's pre…
Matched conditions: HEAD AND NECK CANCER (H&N)
Sponsor: Elephas • Aim: Diagnosis
Last updated Mar 09, 2026 14:25 UTC